Related Experiment Video

Updated: Sep 29, 2026

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

The pregnancy protecting effect of progesterone against human chorionic gonadotrophin challenge in mares

W E Allen

    Irish Veterinary Journal
    |February 1, 1976
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    Abortifacient AgentsAbortion, Drug InducedAbortion, InducedAnimals, LaboratoryBiologyClinical ResearchEndocrine SystemFamily PlanningFertility Control, PostconceptionGonadotropinsGonadotropins, Chorionic--administraction and dosageGonadotropins, Chorionic--side effectsHormonesPhysiologyProgestational HormonesProgesterone--administraction and dosageProgesterone--therapeutic useResearch Methodology

    More Related Videos

    Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm05:44

    Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

    Published on: March 1, 2019

    Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption12:02

    Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

    Published on: July 30, 2016

    Related Concept Videos

    Ovarian Cycle01:27

    Ovarian Cycle

    The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...